MeiraGTx Announces Oral Presentation at ObesityWeek 2026
MeiraGTx Reports Third Quarter 2026 Financial and Operational Results
MeiraGTx Hldgs Q3 EPS $(0.53) Misses $(0.50) Estimate, Sales $4.814M Miss $6.953M Estimate
MeiraGTx Announces Four Posters at the European Society of Gene and Cell Therapy (ESGCT) 2026 Annual Congress and the Network of Excellence for ALS (NEALS) Annual Meeting
MeiraGTx: The Data Held Up, The Valuation Didn't (Rating Downgrade)
Goldman Sachs Initiates Coverage On MeiraGTx Holdings with Neutral Rating, Announces Price Target of $16
MeiraGTx (NASDAQ:MGTX) Clears Minervini Trend Template and High-Growth Momentum Screen
What Could MeiraGTx Holdings (MGTX) New Hires And Profit Swing Signal?
MeiraGTx Seen Nearing First Commercial Launches as Key Programs Advance, RBC Says
RBC Capital Maintains Outperform on MeiraGTx Holdings, Raises Price Target to $27
MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates
MeiraGTx Hldgs Q2 EPS $1.71 Beats $(0.46) Estimate, Sales $321.434M Beat $12.476M Estimate
MeiraGTx Hldgs Q2 Sales $321.434M Beat $12.476M Estimate
MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Wall Street Analysts See a 128.14% Upside in MeiraGTx (MGTX): Can the Stock Really Move This High?
What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near
MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last?
RBC Capital Maintains Outperform on MeiraGTx Holdings, Raises Price Target to $26
HC Wainwright & Co. Reiterates Buy on MeiraGTx Holdings, Maintains $20 Price Target
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.